Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Acceptability, Feasibility and Validity of Genital Self-Sampling for HPV Among Men, PEP 2009-R-01, 12134 [E9-6220]

Download as PDF 12134 Federal Register / Vol. 74, No. 54 / Monday, March 23, 2009 / Notices such as their age and time in the mining industry. Additional data will then be collected at 1, 3, and 6 months after the study commences. The mine workers will be asked to provide their feedback regarding factors such as body part discomfort, usability, durability, and ease of movement. There will be no cost to the respondents. ESTIMATED ANNUALIZED BURDEN HOURS Average burden per response (in hours) Number of responses per respondent Number of respondents Respondents Section Foreman (pilot mine) .......................................................................... Mine Workers (pilot mine—baseline) ............................................................... Mine Workers (pilot mine—one month) ........................................................... Mine Workers (pilot mine—focus group) ......................................................... Section Foreman (full study) ............................................................................ Mine Workers (full study—baseline) ................................................................ Mine Workers (full study—1, 3, and 6 months for control and prototypes) .... 1 9 9 9 6 54 54 1 1 1 1 12 1 6 10/60 20/60 30/60 1 10/60 20/60 25/60 Total .......................................................................................................... ........................ ........................ ........................ Dated: March 11, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–6214 Filed 3–20–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 16, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–6216 Filed 3–20–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel F, Funding Opportunity Announcement (FOA) PAR07–231 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. dwashington3 on PROD1PC60 with NOTICES Total burden (in hours) Time and Date: 2 p.m.–5 p.m., May 12, 2009 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘CDC Grants for Public Health Research Dissertation, Panel F, FOA PAR07– 231.’’ For Further Information Contact: Susan B. Stanton, D.D.S., Scientific Review Officer, Office of the Director, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 30333, Telephone: (404) 639–4640. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices VerDate Nov<24>2008 15:28 Mar 20, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES 0.5 3 4.5 9 12 18 135 182 Atlanta, GA 30333, Telephone (404) 498– 1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 6, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–6220 Filed 3–20–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Acceptability, Feasibility and Validity of Genital SelfSampling for HPV Among Men, PEP 2009–R–01 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 10 a.m.–12 p.m., May 18, 2009 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Acceptability, Feasibility and Validity of Genital Self-Sampling for HPV Among Men, PEP 2009–R–01.’’ Contact Person for More Information: Linda Shelton, Public Health Analyst, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group (NCIPC, IRG) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting: Times and Date: 1 p.m.–1:30 p.m., April 30, 2009 (Open). 1:30 p.m.–6 p.m., April 30, 2009 (Closed). Place: Teleconference, Toll Free: 888–793– 2154, Participant Passcode: 4424802, CDC, Chamblee Campus, Building 106, 4770 Buford Highway, Atlanta, GA 30341. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 74, Number 54 (Monday, March 23, 2009)]
[Notices]
[Page 12134]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6220]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Acceptability, Feasibility and Validity of 
Genital Self-Sampling for HPV Among Men, PEP 2009-R-01

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 10 a.m.-12 p.m., May 18, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Acceptability, Feasibility and 
Validity of Genital Self-Sampling for HPV Among Men, PEP 2009-R-
01.''
    Contact Person for More Information: Linda Shelton, Public 
Health Analyst, Coordinating Center for Health and Information 
Service, Office of the Director, CDC, 1600 Clifton Road, NE., 
Mailstop E21, Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 6, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E9-6220 Filed 3-20-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.